Yes, patients taking Rybelsus (semaglutide) can have a CT scan with contrast if the need is identified by their treating doctor.

Rybelsus (semaglutide) is an oral diabetes medication that does not interact significantly with CT contrasts. Administration of a contrast agent by CT scan is safe for patients taking Rybelsus. Also, no dose adjustment of Rybelsus is necessary for the contrast test.

The attending physician or radiologist decides whether contrast is necessary depending on the medical indication for the imaging test. Contrast may increase the diagnostic value of the test in some diseases.

The GdziePoLek.pl service also allows you to book the medicine at a selected stationary pharmacy and collect it after presenting a prescription:
https://www.gdziepolek.pl/produkty/111644/rybelsus-tabletki/apteki

We also encourage you to familiarize yourself with materials on similar topics:

https://www.gdziepolek.pl/artykuly/jak-przygotowac-sie-do-badan-obrazowych